Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism

Cancer Lett. 2017 Jan 28:385:12-20. doi: 10.1016/j.canlet.2016.10.042. Epub 2016 Nov 5.

Abstract

Vascular recovery or re-angiogenesis after radiotherapy plays a significant role in tumor recurrence, whereas molecular mechanisms of this process remain elusive. In this work, we found that dying glioma cells promoted post-irradiation angiogenesis through a caspase 3 dependent mechanism. Evidence in vitro and in vivo indicated that caspase 3 inhibition undermined proangiogenic effects of dying glioma cells. Proteolytic inactivation of caspase 3 in glioma cells reduced tumorigenicity. Importantly, we identified that NF-κB/COX-2/PGE2 axis acted as downstream signaling of caspase 3, mediating proangiogenic response after irradiation. Additionally, VEGF-A, regulated by caspase 3 possibly through phosphorylated eIF4E, was recognized as another downstream factor participating in the proangiogenic response. In conclusion, these data demonstrated that caspase 3 in dying glioma cells supported the proangiogenic response after irradiation by governing NF-κB/COX-2/PGE2 axis and p-eIF4E/VEGF-A signaling. While inducing caspase 3 activation has been a generally-adopted notion in cancer therapeutics, our study counterintuitively illustrated that caspase 3 activation in dying glioma cells unfavorably supported post-irradiation angiogenesis. This double-edged role of caspase 3 suggested that taming caspase 3 from the opposite side, not always activating it, may provide novel therapeutic strategies due to restricted post-irradiation angiogenesis.

Keywords: Angiogenesis; COX-2/PGE(2); Caspase 3; Irradiation; VEGF-A.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Brain Neoplasms / blood supply
  • Brain Neoplasms / enzymology
  • Brain Neoplasms / pathology
  • Brain Neoplasms / radiotherapy*
  • Caspase 3 / genetics
  • Caspase 3 / metabolism*
  • Caspase Inhibitors / pharmacology
  • Cell Death
  • Cell Line, Tumor
  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / metabolism
  • Dose-Response Relationship, Radiation
  • Enzyme Activation
  • Eukaryotic Initiation Factor-4E / metabolism
  • Female
  • Glioma / blood supply
  • Glioma / enzymology
  • Glioma / pathology
  • Glioma / radiotherapy*
  • Human Umbilical Vein Endothelial Cells / enzymology
  • Humans
  • Mice, Nude
  • NF-kappa B / metabolism
  • Neovascularization, Pathologic*
  • Paracrine Communication
  • Phosphorylation
  • Signal Transduction / radiation effects
  • Transfection
  • Tumor Microenvironment*
  • Vascular Endothelial Growth Factor A / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • Angiogenesis Inhibitors
  • Caspase Inhibitors
  • Eukaryotic Initiation Factor-4E
  • NF-kappa B
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • CASP3 protein, human
  • Caspase 3
  • Dinoprostone